Akcea Therapeutics, Inc. Contract Liability (Deferred Revenue)
Akcea Therapeutics, Inc. had Contract Liability (Deferred Revenue) of $263.00 thousand as of 2020-06-30, per its 10-Q filed 2020-08-05.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2020-08-05
- 2020-06-30: Contract with Customer, Liability, Current $263.00K.
- 2020-03-31: Contract with Customer, Liability, Current $832.00K.
- 2019-12-31: Contract with Customer, Liability, Current $2.17M.
- 2019-09-30: Contract with Customer, Liability, Current $10.84M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2020-06-30 | $263.00K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $832.00K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $2.17M 10-Q · filed 2020-08-05 |
| 2019-09-30 | $10.84M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $15.83M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $21.54M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $25.35M 10-K · filed 2020-03-02 |
| 2018-09-30 | $32.35M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $35.71M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $48.87M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $58.19M 10-K · filed 2019-03-01 |
| 2016-12-31 | $0.00 8-K · filed 2018-09-18 |